CN106912925A - A kind of three high definition preparations and preparation method thereof - Google Patents
A kind of three high definition preparations and preparation method thereof Download PDFInfo
- Publication number
- CN106912925A CN106912925A CN201710197117.7A CN201710197117A CN106912925A CN 106912925 A CN106912925 A CN 106912925A CN 201710197117 A CN201710197117 A CN 201710197117A CN 106912925 A CN106912925 A CN 106912925A
- Authority
- CN
- China
- Prior art keywords
- parts
- preparation
- lemon
- onion
- garlic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 60
- 244000068988 Glycine max Species 0.000 claims abstract description 49
- 235000010469 Glycine max Nutrition 0.000 claims abstract description 49
- 244000131522 Citrus pyriformis Species 0.000 claims abstract description 47
- 235000005979 Citrus limon Nutrition 0.000 claims abstract description 46
- 240000002234 Allium sativum Species 0.000 claims abstract description 45
- 235000004611 garlic Nutrition 0.000 claims abstract description 45
- 241000234282 Allium Species 0.000 claims abstract description 44
- 235000002732 Allium cepa var. cepa Nutrition 0.000 claims abstract description 44
- 235000006886 Zingiber officinale Nutrition 0.000 claims abstract description 41
- 235000008397 ginger Nutrition 0.000 claims abstract description 41
- 235000004347 Perilla Nutrition 0.000 claims abstract description 38
- 238000000855 fermentation Methods 0.000 claims abstract description 37
- 230000004151 fermentation Effects 0.000 claims abstract description 37
- 239000000052 vinegar Substances 0.000 claims abstract description 33
- 235000021419 vinegar Nutrition 0.000 claims abstract description 33
- 239000002002 slurry Substances 0.000 claims abstract description 16
- 239000002994 raw material Substances 0.000 claims abstract description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 11
- 238000002791 soaking Methods 0.000 claims abstract description 6
- 241000234314 Zingiber Species 0.000 claims description 40
- 241000229722 Perilla <angiosperm> Species 0.000 claims description 37
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 28
- 238000011049 filling Methods 0.000 claims description 23
- 238000001914 filtration Methods 0.000 claims description 18
- 239000007788 liquid Substances 0.000 claims description 15
- 235000013336 milk Nutrition 0.000 claims description 14
- 239000008267 milk Substances 0.000 claims description 14
- 210000004080 milk Anatomy 0.000 claims description 14
- 238000007789 sealing Methods 0.000 claims description 12
- 239000000919 ceramic Substances 0.000 claims description 11
- 239000012141 concentrate Substances 0.000 claims description 8
- 230000029087 digestion Effects 0.000 claims description 8
- 239000012530 fluid Substances 0.000 claims description 8
- 238000004321 preservation Methods 0.000 claims description 8
- 239000000047 product Substances 0.000 claims description 8
- 230000001954 sterilising effect Effects 0.000 claims description 8
- 238000004659 sterilization and disinfection Methods 0.000 claims description 8
- 239000000463 material Substances 0.000 claims description 7
- 238000004140 cleaning Methods 0.000 claims description 6
- 238000005520 cutting process Methods 0.000 claims description 5
- 238000004806 packaging method and process Methods 0.000 claims description 5
- 229920000742 Cotton Polymers 0.000 claims description 4
- 239000000706 filtrate Substances 0.000 claims description 4
- 238000003756 stirring Methods 0.000 claims 1
- 239000003814 drug Substances 0.000 abstract description 7
- 230000008901 benefit Effects 0.000 abstract description 5
- 230000006870 function Effects 0.000 abstract description 5
- 230000002218 hypoglycaemic effect Effects 0.000 abstract description 4
- 230000033228 biological regulation Effects 0.000 abstract description 3
- 235000013305 food Nutrition 0.000 abstract description 3
- 235000013402 health food Nutrition 0.000 abstract description 2
- 244000124853 Perilla frutescens Species 0.000 abstract 1
- 244000273928 Zingiber officinale Species 0.000 abstract 1
- 239000012467 final product Substances 0.000 abstract 1
- 238000002156 mixing Methods 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 description 20
- 239000008280 blood Substances 0.000 description 20
- 230000000694 effects Effects 0.000 description 19
- 230000036772 blood pressure Effects 0.000 description 9
- 206010020772 Hypertension Diseases 0.000 description 8
- 208000024172 Cardiovascular disease Diseases 0.000 description 7
- 206010012601 diabetes mellitus Diseases 0.000 description 7
- 231100000614 poison Toxicity 0.000 description 7
- 210000004204 blood vessel Anatomy 0.000 description 6
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 230000002526 effect on cardiovascular system Effects 0.000 description 5
- 230000009286 beneficial effect Effects 0.000 description 4
- 208000026106 cerebrovascular disease Diseases 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000002574 poison Substances 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 230000002354 daily effect Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 201000001421 hyperglycemia Diseases 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 238000012449 Kunming mouse Methods 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000023555 blood coagulation Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 201000005577 familial hyperlipidemia Diseases 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 239000000787 lecithin Substances 0.000 description 2
- 229940067606 lecithin Drugs 0.000 description 2
- 235000010445 lecithin Nutrition 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 230000002040 relaxant effect Effects 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- BGKHCLZFGPIKKU-UHFFFAOYSA-N (13E,15S)-15-hydroxy-9-oxo-prosta-10,13-dienoic acid Natural products CCCCCC(O)C=CC1C=CC(=O)C1CCCCCCC(O)=O BGKHCLZFGPIKKU-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- 206010053567 Coagulopathies Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 208000015710 Iron-Deficiency Anemia Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 108010019160 Pancreatin Proteins 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 210000002565 arteriole Anatomy 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000005961 cardioprotection Effects 0.000 description 1
- 150000003943 catecholamines Chemical class 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 230000035602 clotting Effects 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 239000005555 hypertensive agent Substances 0.000 description 1
- 229940126904 hypoglycaemic agent Drugs 0.000 description 1
- 208000021822 hypotensive Diseases 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- 229940055695 pancreatin Drugs 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000036513 peripheral conductance Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 230000004224 protection Effects 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 238000009781 safety test method Methods 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 235000015424 sodium Nutrition 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 208000018556 stomach disease Diseases 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000041 toxicology testing Toxicity 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710197117.7A CN106912925A (en) | 2017-03-29 | 2017-03-29 | A kind of three high definition preparations and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710197117.7A CN106912925A (en) | 2017-03-29 | 2017-03-29 | A kind of three high definition preparations and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106912925A true CN106912925A (en) | 2017-07-04 |
Family
ID=59461408
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710197117.7A Pending CN106912925A (en) | 2017-03-29 | 2017-03-29 | A kind of three high definition preparations and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106912925A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109289017A (en) * | 2018-08-28 | 2019-02-01 | 深圳市日月神科技有限公司 | For clearing up the composition and preparation method of blood vessel and blood |
CN116439365A (en) * | 2023-04-20 | 2023-07-18 | 江苏黎明食品集团有限公司 | Garlic enzyme production equipment and method |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102793763A (en) * | 2012-09-06 | 2012-11-28 | 苏州谷力生物科技有限公司 | Health-care product capable of preventing and treating high blood pressure |
EP1997500B1 (en) * | 2007-05-29 | 2013-01-02 | Young-Sam Jang | Health tea and method for preparing the same |
CN105011293A (en) * | 2015-07-23 | 2015-11-04 | 夏莹 | Fruit and vegetable herbal beverage |
CN105695286A (en) * | 2016-01-21 | 2016-06-22 | 会泽县溶铺醋业有限责任公司 | Special-flavor ginger vinegar and processing technology thereof |
-
2017
- 2017-03-29 CN CN201710197117.7A patent/CN106912925A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1997500B1 (en) * | 2007-05-29 | 2013-01-02 | Young-Sam Jang | Health tea and method for preparing the same |
CN102793763A (en) * | 2012-09-06 | 2012-11-28 | 苏州谷力生物科技有限公司 | Health-care product capable of preventing and treating high blood pressure |
CN105011293A (en) * | 2015-07-23 | 2015-11-04 | 夏莹 | Fruit and vegetable herbal beverage |
CN105695286A (en) * | 2016-01-21 | 2016-06-22 | 会泽县溶铺醋业有限责任公司 | Special-flavor ginger vinegar and processing technology thereof |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109289017A (en) * | 2018-08-28 | 2019-02-01 | 深圳市日月神科技有限公司 | For clearing up the composition and preparation method of blood vessel and blood |
CN116439365A (en) * | 2023-04-20 | 2023-07-18 | 江苏黎明食品集团有限公司 | Garlic enzyme production equipment and method |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102178756B (en) | Oral liquid for treating high altitude disease (HAD) and preparation method thereof | |
CN103525632B (en) | Health-care wine and preparation method | |
CN101238904B (en) | Chickpea bean sprout juice tea and preparation method and application | |
CN102669348B (en) | Nutrition food of heart nourishing tea granule for nourishing heart | |
CN104430783A (en) | Gingko biscuit | |
CN105851740A (en) | Health-care beverage capable of invigorating stomach and promoting digestion and making method thereof | |
CN104855516A (en) | Preparation method for vinegar-egg milk beverage suitable for conditioning of patients suffering from cardiovascular and cerebrovascular diseases | |
KR20160013227A (en) | Production method of young antler tea | |
CN105861224A (en) | Dendrobium nobile healthcare wine and preparation method thereof | |
CN106912925A (en) | A kind of three high definition preparations and preparation method thereof | |
CN100348238C (en) | Health oral liquid | |
CN102626162B (en) | Nutrition food heart-nourishing tea granule for nourishing hearts | |
CN103948118A (en) | Liquid for preventing and treating hyperlipidemia and preparation method thereof | |
CN107308363A (en) | One kind is calmed the nerves composite essential oil of releiving | |
CN106010855A (en) | Flower-flavored herba dendrobii wine and preparation method thereof | |
CN104435648A (en) | Edible and medicinal dual-purpose composition as well as application and preparation method thereof | |
CN103845670B (en) | Electuary and the preparation method for the treatment of coronary atherosclerosis | |
CN102860378A (en) | Blood pressure reducing health-care persimmon vinegar tea beverage and preparation method thereof | |
CN108102844B (en) | Health wine and preparation method thereof | |
KR20050080501A (en) | A making method of health assistance food for high blood pressure, fatness, diabetes patients. | |
CN104606571A (en) | Fresh spinach root tea substituted drink with effects of helping produce saliva and slaking thirst and preparation method thereof | |
CN104256802A (en) | Formula of snakegourd fruit juice for neutralizing effect of alcoholic drinks | |
CN102626163B (en) | Nutritious food menstruation regulating tea dissolved medicine beneficial for menstruation regulation | |
CN108379500A (en) | A kind of wheat seeding Chinese medicine composition that nourishing the liver Dealcoholic sobering-up is anti-halitosis and preparation method | |
CN109090596A (en) | A kind of Xuancheng's pawpaw paste and preparation method thereof improving damp-heat constitution |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Jue Feng Inventor after: Qin Shufen Inventor before: Jue Feng Inventor before: Qin Shuying |
|
CB03 | Change of inventor or designer information | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20181101 Address after: No. 68, Jianye Road, LIANG Qing District, Nanning, Guangxi Applicant after: Changhong Pharmaceutica Co., Ltd., Guangxi Address before: 530200 68 Jianye Road, LIANG Qing District, Nanning, the Guangxi Zhuang Autonomous Region Applicant before: Changhong Pharmaceutica Co., Ltd., Guangxi Applicant before: Guangxi excellent Biotechnology Co., Ltd. |
|
TA01 | Transfer of patent application right | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170704 |
|
RJ01 | Rejection of invention patent application after publication |